{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:44:07Z","timestamp":1778125447366,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"7050","license":[{"start":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T00:00:00Z","timestamp":1122508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,7,28]],"date-time":"2005-07-28T00:00:00Z","timestamp":1122508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2005,7,28]]},"DOI":"10.1038\/nature03794","type":"journal-article","created":{"date-parts":[[2005,7,27]],"date-time":"2005-07-27T19:11:32Z","timestamp":1122491492000},"page":"568-572","source":"Crossref","is-referenced-by-count":836,"title":["Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system"],"prefix":"10.1038","volume":"436","author":[{"given":"Shiladitya","family":"Sengupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Eavarone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishan","family":"Capila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicki","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanyel","family":"Kiziltepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram","family":"Sasisekharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnature03794_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrc1369","volume":"4","author":"RS Kerbel","year":"2004","unstructured":"Kerbel, R. S. & Kamen, B. A. The anti-angiogenic basis of metronomic chemotherapy. Nature Rev. Cancer 4, 423\u2013436 (2004)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature03794_CR2","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1172\/JCI11223","volume":"106","author":"GL Semenza","year":"2000","unstructured":"Semenza, G. L. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J. Clin. Invest. 106, 809\u2013812 (2000)","journal-title":"J. Clin. Invest."},{"key":"BFnature03794_CR3","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1073\/pnas.072586399","volume":"99","author":"J Tran","year":"2002","unstructured":"Tran, J. et al. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc. Natl Acad. Sci. USA 99, 4349\u20134354 (2002)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature03794_CR4","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1126\/science.1068327","volume":"295","author":"JL Yu","year":"2002","unstructured":"Yu, J. L., Rak, J. W., Coomber, B. L., Hicklin, D. J. & Kerbel, R. S. Effect of p53 status on tumour response to antiangiogenic therapy. Science 295, 1526\u20131528 (2002)","journal-title":"Science"},{"key":"BFnature03794_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1535-6108(03)00336-2","volume":"5","author":"MV Blagosklonny","year":"2004","unstructured":"Blagosklonny, M. V. Antiangiogenic therapy and tumour progression. Cancer Cell 5, 13\u201317 (2004)","journal-title":"Cancer Cell"},{"key":"BFnature03794_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S1535-6108(03)00085-0","volume":"3","author":"S Pennacchietti","year":"2003","unstructured":"Pennacchietti, S. et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3, 347\u2013361 (2003)","journal-title":"Cancer Cell"},{"key":"BFnature03794_CR7","first-page":"1847","volume":"62","author":"EK Rofstad","year":"2002","unstructured":"Rofstad, E. K. et al. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res. 62, 1847\u20131853 (2002)","journal-title":"Cancer Res."},{"key":"BFnature03794_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/nm0903-1104a","volume":"9","author":"MW Kieran","year":"2003","unstructured":"Kieran, M. W., Folkman, J. & Heymach, J. Angiogenesis inhibitors and hypoxia. Nature Med. 9, 1104 (2003)","journal-title":"Nature Med."},{"key":"BFnature03794_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrc905","volume":"2","author":"R Kerbel","year":"2002","unstructured":"Kerbel, R. & Folkman, J. Clinical translation of angiogenesis inhibitors. Nature Rev. Cancer 2, 727\u2013739 (2002)","journal-title":"Nature Rev. Cancer"},{"key":"BFnature03794_CR10","volume-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","author":"BA Chabner","year":"1996","unstructured":"Chabner, B. A., et al. Goodman and Gilman's The Pharmacological Basis of Therapeutics 9th edn (McGraw-Hill, 1996)"},{"key":"BFnature03794_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1046\/j.1365-2613.2002.00211.x","volume":"83","author":"GM Tozer","year":"2002","unstructured":"Tozer, G. M., Kanthou, C., Parkins, C. S. & Hill, S. A. The biology of the combretastatins as tumour vascular targeting agents. Int. J. Exp. Pathol. 83, 21\u201338 (2002)","journal-title":"Int. J. Exp. Pathol."},{"key":"BFnature03794_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0142-9612(94)90197-X","volume":"15","author":"AG Miklos","year":"1994","unstructured":"Miklos, A. G., Lyman, M. D., Freed, L. E. & Langer, R. Wetting of poly(l-lactic acid) and poly(d-lactic-co-glycolic acid) foams for tissue culture. Biomaterials 15, 55\u201358 (1994)","journal-title":"Biomaterials"},{"key":"BFnature03794_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1023\/A:1018908421434","volume":"16","author":"HS Yoo","year":"1999","unstructured":"Yoo, H. S., Oh, J. E., Lee, K. H. & Park, T. G. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release. Pharm. Res. 16, 1114\u20131118 (1999)","journal-title":"Pharm. Res."},{"key":"BFnature03794_CR14","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1096\/fj.04-1934fje","volume":"18","author":"S Sengupta","year":"2004","unstructured":"Sengupta, S., Kiziltepe, T. & Sasisekharan, R. A dual-colour fluorescence imaging-based system for the dissection of antiangiogenic and chemotherapeutic activity of molecules. FASEB J. 18, 1565\u20131567 (2004)","journal-title":"FASEB J."},{"key":"BFnature03794_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nm0901-987","volume":"7","author":"RK Jain","year":"2001","unstructured":"Jain, R. K. Normalizing tumour vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nature Med. 7, 987\u2013989 (2001)","journal-title":"Nature Med."},{"key":"BFnature03794_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1172\/JCI9872","volume":"105","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D., Bergers, G. & Bergsland, E. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumour angiogenesis in mice. J. Clin. Invest. 105, 1045\u20131047 (2000)","journal-title":"J. Clin. Invest."},{"key":"BFnature03794_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc903","volume":"2","author":"TM Allen","year":"2002","unstructured":"Allen, T. M. Ligand-targeted therapeutics in anticancer therapy. Nature Rev. Drug Discov. 2, 750\u2013763 (2002)","journal-title":"Nature Rev. Drug Discov."},{"key":"BFnature03794_CR18","first-page":"3752","volume":"55","author":"F Yuan","year":"1995","unstructured":"Yuan, F. et al. Vascular permeability in a human tumour xenograft: molecular size dependence and cutoff size. Cancer Res. 55, 3752\u20133756 (1995)","journal-title":"Cancer Res."},{"key":"BFnature03794_CR19","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1158\/0008-5472.CAN-04-0074","volume":"64","author":"RT Tong","year":"2004","unstructured":"Tong, R. T. et al. Vascular normalization by vascular endothelial growth facor receptor-2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 64, 3731\u20133736 (2004)","journal-title":"Cancer Res."},{"key":"BFnature03794_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm0202-121","volume":"8","author":"W Arap","year":"2002","unstructured":"Arap, W. et al. Steps toward mapping the human vasculature by phage display. Nature Med. 8, 121\u2013127 (2002)","journal-title":"Nature Med."},{"key":"BFnature03794_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000)","journal-title":"Cell"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nature03794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature03794","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nature03794.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:46:42Z","timestamp":1684432002000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature03794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7,28]]},"references-count":21,"journal-issue":{"issue":"7050","published-print":{"date-parts":[[2005,7,28]]}},"alternative-id":["BFnature03794"],"URL":"https:\/\/doi.org\/10.1038\/nature03794","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7,28]]}}}